Intranasal treatment of the intracerebroventricular-streptozotocin (ICV-STZ)-induced mouse model of Alzheimer’s disease with the insulin sensitizer metformin improved learning and memory without altering the blood levels of glucose [68]. The gene discussed is INS; the disease is Alzheimer disease.